Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF

Who May Qualify: - Adults age 19 and above ( no age limit for elderly ) - Patients with cardiogenic shock requiring intensive care monitoring in ICU - Patients eligible for oral medication administration - Patients who have provided research participation consent through a written willing to sign a consent form form Who Should NOT Join This Trial: - Unwilling or unable to obtain willing to sign a consent form by the participant or substitute decision maker - Patients with mechanical circulatory support at the time of screening - Patients with acute coronary syndrome - Patients with severe valvular heart disease requiring emergent percutaneous procedures or surgery - Known hypersensitivity to beta-blockers - Patients with a history of bronchospasm or asthma - Patients with bradycardia or second or third-degree atrioventricular block - Patients with sick sinus syndrome, including sinoatrial block - Patients with untreated pheochromocytoma - Patients currently undergoing de-sensitization therapy - Patients who are currently pregnant, postpartum period within 30 days or breast-feeding Always talk to your doctor about whether this trial is right for you.